Boston Therapeutics, Inc (BTHE)
Today, BTHE remains (0.00%) +0.000 at $1.10 thus far (ref. google finance Delayed: 12:25PM EDT October 10, 2013).
Boston Therapeutics has previously closed the final tranche of approximately $1.8 million to bring total gross proceeds of approximately $5.3 million from the private placement of Common Stock and warrants to existing and new accredited investors (the “Offering”).
Proceeds of the offering will be used to fund additional clinical trials for PAZ320, a non-systemic chewable drug designed to reduce the elevation of postprandial glucose or post-meal blood sugar for treatment of patients with Type 2 diabetes, and for general corporate purposes. PAZ320 is the first compound in a new class of therapies for this disease.
North Boston Therapeutics, Inc (BTHE) 5 day chart:
Crown Equity Holdings Inc. (CRWE)
Crown Equity Holdings Inc. (OTCMKTS:CRWE) (www.crownequityholdings.com) together with its digital network of Websites, offers advertising branding and marketing services as a worldwide online multi-media publisher.
Today, The Company remains (0.00%) +0.000 at $.005 with 2,800,000 shares in play thus far (ref. google finance Delayed: 12:36PM EDT October 10, 2013).
The Company previously reported their decision to focus its strategic plan for future growth and services with its original online manufactures and buyer's marketplace solution.
Crown Equity Holdings Inc. focused its efforts and direction to an attempted launched earlier this year in significance to an online business-to-business (B2B) marketplace platform for manufacturers and small to large businesses on a global basis to sell and acquire various types of merchandise. The company has started updating its B2B business plan and plans of action to move forward.
Top Clean Energy Stocks To Watch For 2014
Crown Equity Holdings Inc. (CRWE) 5 day chart:
No comments:
Post a Comment